| Pulmozyme |
103532 |
001 |
351(a) |
dornase alfa |
Solution |
Inhalation |
2.5MG/2.5ML (1MG/ML) |
Ampule |
1993/12/30
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Trasylol |
020304 |
001 |
351(a) |
aprotinin |
Injection |
Intravenous |
1,000,000KIU/100ML (10,000KIU/ML) |
Single-Dose Vial |
1993/12/29
|
Bayer HealthCare Pharmaceuticals Inc. |
Disc |
Licensed |
N/A |
N/A |
| Trasylol |
020304 |
002 |
351(a) |
aprotinin |
Injection |
Intravenous |
2,000,000KIU/200ML (10,000KIU/ML) |
Single-Dose Vial |
1993/12/29
|
Bayer HealthCare Pharmaceuticals Inc. |
Disc |
Licensed |
N/A |
N/A |
| Nutropin |
020168 |
001 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
5MG |
Multi-Dose Vial |
1993/11/17
|
Genentech, Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Nutropin |
020168 |
002 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
10MG |
Multi-Dose Vial |
1993/11/17
|
Genentech, Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Betaseron |
103471 |
001 |
351(a) |
interferon beta-1b |
For Injection |
Subcutaneous |
0.3MG |
Single-Dose Vial |
1993/07/23
|
Bayer HealthCare Pharmaceuticals Inc. |
Rx |
Licensed |
N/A |
N/A |
| Bioclate (Armour), Recombinate |
103375 |
001 |
351(a) |
Antihemophilic Factor (Recombinant) |
For Injection |
Intravenous |
1000IU |
Single-Dose Vial |
1992/12/10
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Bioclate (Armour), Recombinate |
103375 |
002 |
351(a) |
Antihemophilic Factor (Recombinant) |
For Injection |
Intravenous |
500IU |
Single-Dose Vial |
1992/12/10
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Bioclate (Armour), Recombinate |
103375 |
003 |
351(a) |
Antihemophilic Factor (Recombinant) |
For Injection |
Intravenous |
250IU |
Single-Dose Vial |
1992/12/10
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Orthoclone OKT3 |
103463 |
001 |
351(a) |
muromonab-CD3 |
Injection |
Intravenous |
1MG/ML |
Ampule |
1992/09/14
|
Centocor Ortho Biotech Products, L.P. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Proleukin |
103293 |
001 |
351(a) |
aldesleukin |
For Injection |
Intravenous |
22MILLION INTERNATIONAL UNITS (1.3MG) |
Single-Dose Vial |
1992/05/05
|
Iovance Biotherapeutics Manufacturing LLC |
Rx |
Licensed |
N/A |
N/A |
|
103317 |
001 |
351(a) |
Positive Skin Test Control-Histamine |
Injection |
Percutaneous |
1.8MG/ML |
Vial |
1992/02/14
|
Nielsen Bioscience, Inc |
Disc |
Licensed |
|
N/A |
| Thrombate Iii |
103196 |
001 |
351(a) |
Antithrombin III (Human) |
For Injection |
Intravenous |
500IU |
Single-Dose Vial |
1991/12/30
|
Grifols Therapeutics LLC |
Rx |
Licensed |
|
N/A |
| Botox Cosmetic |
103000 |
001 |
351(a) |
onabotulinumtoxinA |
For Injection |
Intramuscular |
50UNITS |
Single-Dose Vial |
1991/12/09
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Botox Cosmetic |
103000 |
002 |
351(a) |
onabotulinumtoxinA |
For Injection |
Intramuscular |
100UNITS |
Single-Dose Vial |
1991/12/09
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Botox |
103000 |
003 |
351(a) |
onabotulinumtoxinA |
For Injection |
Injection, Intramuscular, Intradermal, Intradetrusor |
50UNITS |
Single-Dose Vial |
1991/12/09
|
AbbVie Inc. |
Disc |
Licensed |
N/A |
N/A |
| Botox |
103000 |
004 |
351(a) |
onabotulinumtoxinA |
For Injection |
Injection, Intramuscular, Intradermal, Intradetrusor |
100UNITS |
Single-Dose Vial |
1991/12/09
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Botox |
103000 |
005 |
351(a) |
onabotulinumtoxinA |
For Injection |
Injection, Intramuscular, Intradermal, Intradetrusor |
200UNITS |
Single-Dose Vial |
1991/12/09
|
AbbVie Inc. |
Rx |
Licensed |
N/A |
N/A |
| Pharmalgen |
103969 |
001 |
351(a) |
Venoms, Honey Bee Venom |
For Injection |
Subcutaneous |
100UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |
| Pharmalgen |
103969 |
002 |
351(a) |
Venoms, Honey Bee Venom |
For Injection |
Intradermal |
100UG/ML |
Multi-Dose Vial |
1991/10/08
|
ALK - Abello A/S |
Disc |
Voluntarily Revoked |
|
N/A |